VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 40 filers reported holding VYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,421 | -32.9% | 89,472 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -42.9% | 89,472 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -39.7% | 89,472 | 0.0% | 0.00% | – |
| Q1 2022 | $58,000 | -36.3% | 89,472 | -0.0% | 0.00% | – |
| Q4 2021 | $91,000 | -57.3% | 89,477 | -41.7% | 0.00% | – |
| Q3 2021 | $213,000 | -38.4% | 153,553 | +55.9% | 0.00% | – |
| Q2 2021 | $346,000 | -87.1% | 98,524 | -74.9% | 0.00% | -100.0% |
| Q1 2021 | $2,692,000 | – | 393,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,100,000 | $1,529,000 | 1.55% |
| Healthcare Value Capital, LLC | 400,000 | $556,000 | 1.10% |
| CM Management, LLC | 143,750 | $200,000 | 0.15% |
| Perceptive Advisors | 2,330,471 | $3,239,000 | 0.05% |
| 683 Capital Management, LLC | 715,386 | $994,000 | 0.04% |
| Virtu Financial LLC | 108,319 | $151,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 92,402 | $128,000 | 0.01% |
| Platform Technology Partners | 14,457 | $20,000 | 0.01% |
| Tekla Capital Management LLC | 135,395 | $188,000 | 0.01% |
| DELTEC ASSET MANAGEMENT LLC | 30,000 | $42,000 | 0.01% |